Literature DB >> 34115241

Lipopolysaccharides increase the risk of colorectal cancer recurrence and metastasis due to the induction of neutrophil extracellular traps after curative resection.

Wei-Wei Wang1, Lipei Wu2, Wenying Lu3, Wei Chen3, Wenhui Yan3, Chunrun Qi1, Shihai Xuan4, Anquan Shang5.   

Abstract

BACKGROUND: Intra-abdominal infection after curative surgery for colorectal cancer is a serious complication associated with an increased risk of recurrence. Lipopolysaccharides (LPS)-an essential component of the cell wall of Gram-negative bacteria-were found to exert a protumorigenic effect by stimulating the inflammatory pathology and formation of neutrophil extracellular traps (NETs). This study was conducted to test whether LPS-induced formation of NETs promotes the development of cancer and metastasis.
METHODS: The clinical characteristics, incidence of relapse, and serum myeloperoxidase-DNA complexes of 40 patients with infection and 40 patients without infection after curative surgery were analyzed. The effects of LPS on the induction of NETs were evaluated in a mouse model of colorectal cancer and liver metastasis. The toll-like receptor 9 (TLR9)-a DNA receptor-was knocked down to assess its effect on the mitogen-activated protein kinase pathway and activities implicated in the formation of NETs.
RESULTS: Analysis of the clinical data obtained from these patients showed the significant relation of the formation of NETs and incidence of metastasis and survival rates. Subsequent in vitro experiments revealed an increased level of citrullinated-histone H3 and myeloperoxidase-DNA in LPS-injected mice with colorectal cancer. In the mimic metastatic model, injection of LPS enhanced the metastatic capacity, which was then attenuated by DNase I. This suggested that the formation of NETs was activated by LPS. Injection of TLR9-knockdown HCT116 cells in mice, followed by induction through LPS, mitigated the level of citrullinated-histone H3 and myeloperoxidase-DNA. This finding implied that the formation of NETs was suppressed.
CONCLUSION: These findings shed light on the mechanism underlying the relationship between the elevated rate of colorectal cancer recurrence in patients who underwent surgery and the incidence of infection. This mechanism involves the protumorigenic activities of LPS-induced formation of NETs. The NETs which could be mediated by the TLR9 and the mitogen-activated protein kinase signaling pathway.

Entities:  

Keywords:  Colorectal cancer; Lipopolysaccharides; Metastasis; Neutrophil extracellular traps; Recurrence

Year:  2021        PMID: 34115241     DOI: 10.1007/s00432-021-03682-8

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  41 in total

1.  Neutrophil extracellular traps kill bacteria.

Authors:  Volker Brinkmann; Ulrike Reichard; Christian Goosmann; Beatrix Fauler; Yvonne Uhlemann; David S Weiss; Yvette Weinrauch; Arturo Zychlinsky
Journal:  Science       Date:  2004-03-05       Impact factor: 47.728

Review 2.  Postoperative leakage and abscess formation after colorectal surgery.

Authors:  W M Chambers; N J McC Mortensen
Journal:  Best Pract Res Clin Gastroenterol       Date:  2004-10       Impact factor: 3.043

3.  Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood.

Authors:  Stephen R Clark; Adrienne C Ma; Samantha A Tavener; Braedon McDonald; Zahra Goodarzi; Margaret M Kelly; Kamala D Patel; Subhadeep Chakrabarti; Erin McAvoy; Gary D Sinclair; Elizabeth M Keys; Emma Allen-Vercoe; Rebekah Devinney; Christopher J Doig; Francis H Y Green; Paul Kubes
Journal:  Nat Med       Date:  2007-03-25       Impact factor: 53.440

4.  Lipopolysaccharide induces cytokine production and decreases extravillous trophoblast invasion through a mitogen-activated protein kinase-mediated pathway: possible mechanisms of first trimester placental dysfunction.

Authors:  Lauren Anton; Amy G Brown; Samuel Parry; Michal A Elovitz
Journal:  Hum Reprod       Date:  2011-11-03       Impact factor: 6.918

5.  Bridging the gap: the village health worker as the cornerstone of the primary health care model.

Authors:  D E Bender; K Pitkin
Journal:  Soc Sci Med       Date:  1987       Impact factor: 4.634

Review 6.  Systematic review of the definition and measurement of anastomotic leak after gastrointestinal surgery.

Authors:  J Bruce; Z H Krukowski; G Al-Khairy; E M Russell; K G Park
Journal:  Br J Surg       Date:  2001-09       Impact factor: 6.939

7.  Anastomotic leakage after curative anterior resection results in a higher prevalence of local recurrence.

Authors:  S W Bell; K G Walker; M J F X Rickard; G Sinclair; O F Dent; P H Chapuis; E L Bokey
Journal:  Br J Surg       Date:  2003-10       Impact factor: 6.939

8.  Postoperative intra-abdominal infection increases angiogenesis and tumor recurrence after surgical excision of colon cancer in mice.

Authors:  Bernhard Bohle; Miguel Pera; Marta Pascual; Sandra Alonso; Xavier Mayol; Margarita Salvado; Jan Schmidt; Luis Grande
Journal:  Surgery       Date:  2009-09-20       Impact factor: 3.982

9.  Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis.

Authors:  Jonathan Cools-Lartigue; Jonathan Spicer; Braedon McDonald; Stephen Gowing; Simon Chow; Betty Giannias; France Bourdeau; Paul Kubes; Lorenzo Ferri
Journal:  J Clin Invest       Date:  2013-07-01       Impact factor: 14.808

10.  Systematic review of anastomotic leakage rate according to an international grading system following anterior resection for rectal cancer.

Authors:  Zhi-Jie Cong; Liang-Hao Hu; Zheng-Qian Bian; Guang-Yao Ye; Min-Hao Yu; Yun-He Gao; Zhao-Shen Li; En-Da Yu; Ming Zhong
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

View more
  1 in total

Review 1.  The emerging role of neutrophilic extracellular traps in intestinal disease.

Authors:  Feng Chen; Yongqiang Liu; Yajing Shi; Jianmin Zhang; Xin Liu; Zhenzhen Liu; Jipeng Lv; Yufang Leng
Journal:  Gut Pathog       Date:  2022-06-22       Impact factor: 5.324

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.